维普期刊资源整合服务平台（V6.5）

44篇 您的检索式：作者名="Blanchette P"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis:Canadian Hemophilia Primary Prophylaxis (CHPS) Study显示文摘	Hilliard P Zourikian N Blanchette V	2013	J Thromb Haemost2013，11，3：	1
2	Cost-utility analysis of Canadian tailored prophylaxis,primary prophylaxis and ondemand therapy in young children with severe haemophilia A显示文摘	Risebrough N Oh P Blanchette V	2008	Haemophilia2008，14，4：	1
3	Antiviral activity of CHOSS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses显示文摘	Buckwold V E Wei J Huang Z Huang C Nalca A Wells J Russell J Collins B Ptak R Lang W Scribner C Blanchett D Alessi T Langecker P	2007	AntiviralResearch2007，73，2：	1
4	Childhood immune thrombocytopenic purpura: diagnosis and management 显示文摘	Blanchette V Bolton-Maggs P	2010	Hematol Oncol Clin North Am2010，24，1：	1
5	PID gain scheduling using fuzzy logic显示文摘	BLANCHETT T P KEMBER G C DUBAY R	2000	ISA Transactions2000，39，3：	1
6	P1D Gain Scheduling Using Fuzzy LogJc显示文摘	Blanchett T P Kember G C Dubay R	2000	JSA Transactions2000，39，：	1
7	Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A显示文摘	Risebrough N Oh P Blanchette V	2008	Haemophilia2008，14，：	1
8	Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immuune thrombocytopenic purpura 显示文摘	Blanchette V Imbach P Andrew M	1994	Lancet1994，344，8924：	1
9	Partial coalescence of drops at liquid interface 显示文摘	Blanchette F Bigioni T P	2006	Nature Physics2006，2，4：	1
10	A state-space modeling approach for the FPGA-based real-time simulation of high switching frequency power converters显示文摘	BLANCHETTE H F OULD-BACHIR T DAVID J P	2012	IEEE Trans on Industrial Electronics2012，59，12：	1
11	Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend显示文摘	BLANCHETTE C M GROSS N J ALTMAN P	2014	Am Health Drug Benefits2014，7，2：	1
12	Musculoskeletal health of subjects with hemophilia A treatedwith tailored prophylaxis : Canadian Hemophilia PrimaryProphylaxis ( CHPS) Study 显示文摘	HILLIARD P ZOURIKIAN N BLANCHETTE V	2013	J Thromb Haemost2013，11，3：	1
13	Cost-utili-ty analysis of Canadian tailored prophylaxis,primary prophy-laxis and on- demand therapy in young children with severehaemophilia A显示文摘	RISEBROUGH N OH P BLANCHETTE V	2008	Haemophilia2008，14，4：	1
14	PID gain scheduling using fuzzy logic显示文摘	T P Blanchett G C Kember R Dubay	2000	ISA Transactions2000，39，：	1
15	Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment显示文摘	Barnes C Blanchette V Canning P	2005	Transfus Med2005，15，2：	1
16	Involvement ofSmads in TGFbetal - induced furin (fur) transcription显示文摘	Blanchette F Rudd P Grondin F	2001	JCell Physiol2001，188，2：	1
17	Childhood immune thrombocytopenic purpura : Diagnosis and management 显示文摘	Blanchette V Bohon - Maggs P	2008	Pediatr Clin North Am2008，55，2：	1
18	The role of bisphosphonates in early-and advanced-stage breast cancer:have we finally optimized care显示文摘	Blanchette P S Pritchard K I	2015	Oncology(Williston Park)2015，29，1：	1
19	Childhood immune thrombocytopenicpurpura:Diagnosis and management显示文摘	Blanchette V Bolton-Maggs P	2010	Hematol Oncol Clin N2010，24，1：	1
20	Childhood immune thrombocytopenic purpura:diagnosis and management显示文摘	Blanchette V BohonMaggs P	2008	Pediatr Clin North Am2008，55，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示